VIKING THERAPEUTICS INC
CUSIP 92686J956
Viking Therapeutics Inc has 1 institutional holders in Filings Flow’s 13F database, together reporting 9.8K shares worth $318,000 as of Q1 2026. The largest reported holders are Imc-Chicago, LLC, Group One Trading LLC, and Jpmorgan Chase & Co.
Institutional Holders
1
Q1 2026
Reported Value
$318,000
Ticker
unmapped
private placement or foreign
Quarters Tracked
2
Ownership Trend
Institutional holders
Total reported value
Holders
··Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| IMC-Chicago, LLC$278.4B AUM | 0.00% | $3M | 104.4K | Q1 2026 |
| GROUP ONE TRADING LLC$52.2B AUM | 0.00% | $1M | 38.2K | Q1 2026 |
| JPMORGAN CHASE & CO$1.56T AUM | 0.00% | $897,600 | 30.0K | Q1 2026 |
| SIMPLEX TRADING, LLC$149.1B AUM | 0.00% | $745,166 | 22.9K | Q1 2026 |
| HRT FINANCIAL LP$40.1B AUM | 0.00% | $318,000 | 9.8K | Q1 2026 |
| Persistent Asset Partners Ltd$268M AUM | 0.02% | $52,532 | 851 | Q4 2025OLDER |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC.$0 AUM | — | $0 | 0 | Q2 2025OLDER |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.